Literature DB >> 24859327

The incidence of mismatch repair gene defects in colorectal liver metastases.

Raul Alvarado-Bachmann1, Adrian Smith2, Justin S Gundara1, Samuel C L Kuo1, Anthony J Gill3, Jaswinder S Samra1, Thomas J Hugh1.   

Abstract

Knowledge of the molecular biology of primary colorectal cancer (CRC) has improved in recent years, and one reason for this is the identification of microsatellite instability (MSI), which occurs in up to 15% of sporadic CRC. However, less is known regarding the processes involved in colorectal liver metastases (CRLM). Increasing numbers of patients with CRLM are suitable for curative resection, so the identification of molecular markers may improve patient selection. The aim of the present study was to characterise the incidence of MSI in resected CRLM. Fifty‑one sequentially resected CRLM specimens were selected. Clinicopathologic data was collated and immunohistochemistry for MLH1 and MSH2 was performed on paraffin sections of the CRLM specimens. The association between abnormal staining and the clinicopathological data was examined. The median age of the subjects in the current study was 65 years, the average number of CRLM was 2 and the median overall survival time was 42.1 months post liver resection. None of the 50 resected specimens demonstrated abnormal staining for MLH1 or MSH2. Compared with the previously reported incidence of MSI in primary CRC, the low incidence of MSI in the current cohort of CRLM precludes its use as a marker for use in making clinical decisions regarding this condition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24859327     DOI: 10.3892/mmr.2014.2257

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  4 in total

1.  Immune Contexture of MMR-Proficient Primary Colorectal Cancer and Matched Liver and Lung Metastases.

Authors:  Maarit Ahtiainen; Hanna Elomaa; Juha P Väyrynen; Erkki-Ville Wirta; Teijo Kuopio; Olli Helminen; Toni T Seppälä; Ilmo Kellokumpu; Jukka-Pekka Mecklin
Journal:  Cancers (Basel)       Date:  2021-03-26       Impact factor: 6.639

Review 2.  Colorectal liver metastasis: molecular mechanism and interventional therapy.

Authors:  Hui Zhou; Zhongtao Liu; Yongxiang Wang; Xiaoyong Wen; Eric H Amador; Liqin Yuan; Xin Ran; Li Xiong; Yuping Ran; Wei Chen; Yu Wen
Journal:  Signal Transduct Target Ther       Date:  2022-03-04

3.  Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer.

Authors:  Guoying Zhou; Lisanne Noordam; Dave Sprengers; Michail Doukas; Patrick P C Boor; Adriaan A van Beek; Remco Erkens; Shanta Mancham; Dirk Grünhagen; Anand G Menon; Johan F Lange; Pim J W A Burger; Alexandra Brandt; Boris Galjart; Cornelis Verhoef; Jaap Kwekkeboom; Marco J Bruno
Journal:  Oncoimmunology       Date:  2018-04-25       Impact factor: 8.110

4.  Prognostic implications of EGFR protein expression in sporadic colorectal tumors: Correlation with copy number status, mRNA levels and miRNA regulation.

Authors:  Sofía Del Carmen; Luís Antonio Corchete; Ruth Gervas; Alba Rodriguez; María Garcia; José Antonio Álcazar; Jacinto García; Oscar Bengoechea; Luis Muñoz-Bellvis; José María Sayagués; Mar Abad
Journal:  Sci Rep       Date:  2020-03-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.